Skip to Main Content

Rebecca L. Olin

MD MSCE

Hematologist

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells).

In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant.

Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania.

  • Education

    Perelman School of Medicine, 2003

    University of Pennsylvania, MS, Clinical Epidemiology , 2009

  • Residencies

    Hospital of the University of Pennsylvania, Internal Medicine, 2006

  • Fellowships

    Hospital of the University of Pennsylvania, Hematology-Oncology, 2009

  • Board Certifications

    Medical Oncology, American Board of Internal Medicine

  • Academic Title

    Associate Professor

  • Languages

    French

Where I see patients (1)

    My reviews

    4.9

    Overall Experience
    142 Ratings
    About our process
    Feb 28, 2023
    She was great. Explained everything very clearly and answered all our questions
    Feb 14, 2023
    She is terrific! Knowledgeable kind good listener.
    Feb 02, 2023
    Dr Olin is one of the best physicians I ever meat in my life as a clinician and patien.
    Jan 16, 2023
    The call was scheduled for 12:45pm and missed the call time. She did call while I was at another 2nd doctor appointment and cut into that appt.
    Dec 16, 2022
    Excellent would better describe dr Olin
    Oct 30, 2022
    Dr olin is friendly and professional
    Oct 27, 2022
    She is so helpful with clear explanations.
    Oct 21, 2022
    Dr. Olin is excellent patient kind and easy to communicate with. I feel confident in her care.
    Oct 10, 2022
    Dr Olin is always extremely patient and shows concern about my condition and takes the time to go over of all my questions. She is very knowledgeable and make it easy for me to understand what is going on. She is compatienent and easy to talk to. She is also a good listener and provide the best patient care anyone can receive.
    May 24, 2022
    UCSF is the best health care I've ever recieved thank you
    May 05, 2022
    We love dr Olin thank you
    Apr 28, 2022
    Great experience
    Mar 05, 2022
    Dr. Olin is a terrific doctor in every way.
    Jan 27, 2022
    I look forward to walking through my Primary Myelofibrosis journey with Dr. Olin and the UCSF team by my side.
    Jan 20, 2022
    Dr. Olin is fantastic!
    Jan 14, 2022
    Very satisfied
    Nov 16, 2021
    I honestly would not be alive today without Dr. Olin and UCSF I cannot thank you enough from my heart
    Nov 02, 2021
    Dr. Olin is involved in my health care plan 100%
    Oct 28, 2021
    Very stress-free and professional
    Oct 05, 2021
    She was very patient and ask me my imput into most matters.
    Jul 15, 2021
    I have received excellent care from Dr R Olin for a number of years. She leads my care and coordinates with an oncologist locally so that I don't have as many trips into San Francisco to the UCSF Medical Center.
    Jun 15, 2021
    Dr. Olin is the best Oncologist I have ever worked with thank you : )
    May 27, 2021
    Best Dr I ever had. Patient informative and very smart.
    Decorative Caduceus

    Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Tra...

    The arm with the largest mean change in Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) from baseline to day 90. The Wilcoxon rank-sum test will be used to compare change in FACT-BMT between arms, and thi...

    Recruiting

    Decorative Caduceus

    Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

    The feasibility of completing molecular, genetic, immunophenotypic, and biochemical testing for assignment of therapy will be assessed based on the proportion of patients for whom testing is completed within 7 days of the registra...

    Recruiting

    Decorative Caduceus

    Study Evaluating Safety and Efficacy of UCART123 in Patients With Relapsed/ Refractory Acute My...

    Safety of UCART123v1.2 - Incidence, nature, and severity of adverse events and serious adverse events (SAEs) throughout the study

    Recruiting

    Share